The U.S. pharmaceutical giant Pfizer divests its non-core businesses and
sells the world's largest pharmaceutical capsule producers Capsugel
to the investment company KKR. The financial investor will pay about
USD 2.4 billion
for the company
. At the same time, the company lowered
its revenue forecast slightly. Pfizer had already
announced in October
that it plans to consider a separation of Capsugel. The Pfizer's daughter generated an annual turnover of around
USD 750 million
. In addition to hard capsules made of gelatin
, the company
Capsules to different Pharmaceutical companies
. Because of the separation, Pfizer lowered its sales targets
for this and the
next few years. Pfizer
now expects sales for 2011
of USD 65.2 to 67.2 billion before USD 66-68 billion.
Pfizers stock price closed at USD 20.54. The current dividend yield of the company amounts to 3.9 percent while the P/E ratio amounts to 20.01.
Since December 01, 2010, the stock price of PFE is still rising and gained by 22.9 percent. Do you believe that the company made a turn?